Association between cannabis use and physical activity in the United States based on legalization and health status | Journal of Cannabis Research
Aldington S, Williams M, Nowitz M, Weatherall M, Pritchard A, McNaughton A, Robinson G, Beasley R. Effects of cannabis on pulmonary structure, function and symptoms. Thorax. 2007;62(12):1058–63. https://doi.org/10.1136/thx.2006.077081.
Anderson E, Durstine JL. Physical activity, exercise, and chronic diseases: a brief review. Sports Med Health Sci. 2019;1(1):3–10. https://doi.org/10.1016/j.smhs.2019.08.006.
Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants. 2019;9(1):21. https://doi.org/10.3390/antiox9010021.
Azofeifa A, Mattson ME, Schauer G, McAfee T, Grant A, Lyerla R. National estimates of marijuana use and related indicators: National Survey on Drug Use and Health, United States, 2002–2014. MMWR Surveill Summ. 2016;65(11):1–28. https://doi.org/10.15585/mmwr.ss6511a1.
Blessing EM, Steenkamp MM, Manzanares J, Marmar CR. Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics. 2015;12(4):825–36. https://doi.org/10.1007/s13311-015-0387-1.
Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol. 2012;2(2):1143–211. https://doi.org/10.1002/cphy.c110025.
Boutouis S, Wymbs F, Franz B. The association between marijuana and e-cigarette use and exercise behavior among adults. Prev Med Rep. 2024;40:102668. https://doi.org/10.1016/j.pmedr.2024.102668.
Brisola-Santos MB, Gallinaro JG, Gil F, Sampaio-Junior B, Marin MC, de Andrade AG, Richter KP, Glick ID, Baltieri DA, Castaldelli-Maia JM. Prevalence and correlates of cannabis use among athletes-A systematic review. Am J Addict. 2016;25(7):518–28. https://doi.org/10.1111/ajad.12425.
Burr JF, Cheung CP, Kasper AM, Gillham SH, Close GL. Cannabis and athletic performance. Sports Med. 2021;51(Suppl 1):75–87. https://doi.org/10.1007/s40279-021-01505-x.
Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance. About BRFSS. 2024. https://www.cdc.gov/brfss/about/index.htm. Accessed 28 September 2024.
Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2016 summary data quality report. https://www.cdc.gov/brfss/annual_data/2016/pdf/2016-sdqr.pdf. Accessed 11 April 2024.
Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2017 summary data quality report. https://www.cdc.gov/brfss/annual_data/2017/pdf/2017-sdqr-508.pdf. Accessed 11 April 2024.
Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2018 summary data quality report. https://www.cdc.gov/brfss/annual_data/2018/pdf/2018-sdqr-508.pdf. Accessed 11 April 2024.
Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2019 summary data quality report. https://www.cdc.gov/brfss/annual_data/2019/pdf/2019-sdqr-508.pdf
Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2020 summary data quality report. https://www.cdc.gov/brfss/annual_data/2020/pdf/2020-sdqr-508.pdf. Accessed 11 April 2024.
Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2021 summary data quality report. https://www.cdc.gov/brfss/annual_data/2021/pdf/2021-dqr-508.pdf. Accessed 11 April 2024.
Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2022 summary data quality report. https://www.cdc.gov/brfss/annual_data/2022/pdf/2022-dqr-508.pdf. Accessed 11 April 2024.
Chaves YC, Genaro K, Stern CA, de Oliveira Guaita G, de Souza Crippa JA, da Cunha JM, Zanoveli JM. Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes. Neurosci Lett. 2020;729:135020. https://doi.org/10.1016/j.neulet.2020.135020.
Dai H, Richter KP. A national survey of marijuana use among US adults with medical conditions, 2016–2017. JAMA Netw Open. 2019;2(9):e1911936. https://doi.org/10.1001/jamanetworkopen.2019.11936.
Docter S, Khan M, Gohal C, Ravi B, Bhandari M, Gandhi R, Leroux T. Cannabis use and sport: a systematic review. Sports Health. 2020;12(2):189–99. https://doi.org/10.1177/1941738120901670.
Ehud Z, Lola W, Itamar R, Natan P, Zhanna Y, Ruth G. Islet protection and amelioration of diabetes type 2 in Psammomys obesus by treatment with cannabidiol. J Diabetes Mellitus. 2012;02(01):27–34. https://doi.org/10.4236/jdm.2012.21005.
Failing CJ, Boehnke KF, Riebschleger M. Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2021;19(1):171. https://doi.org/10.1186/s12969-021-00656-5.
Forbes Health. Your Guide to Cannabis Legalization by State. https://www.forbes.com/health/cbd/cannabis-legalization-by-state/. Accessed 8 August 2024.
Frane N, Stapleton E, Iturriaga C, Ganz M, Rasquinha V, Duarte R. Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study. J Cannabis Res. 2022;4(1):47. https://doi.org/10.1186/s42238-022-00154-9
French MT, Mortensen K, Kovalski MA. The relationships between marijuana use and exercise among young and middle-aged adults. Prev Med. 2021;147:106518. https://doi.org/10.1016/j.ypmed.2021.106518.
Grogan G, Stephens K, Chou J, Timko MP, Cottler P, DeGeorge BR Jr. The mechanism of cannabichromene and cannabidiol alone versus in combination in the alleviation of arthritis-related inflammation. Ann Plast Surg. 2023;90(6S Suppl 4):S408–S15. https://doi.org/10.1097/SAP.0000000000003547
Hasbi A, Madras BK, George SR. Endocannabinoid system and exogenous cannabinoids in depression and anxiety: a review. Brain Sci. 2023;13(2):325. https://doi.org/10.3390/brainsci13020325.
Healthy People 2030. Behavioral Risk Factor Surveillance System (BRFSS). https://health.gov/healthypeople/objectives-and-data/data-sources-and-methods/data-sources/behavioral-risk-factor-surveillance-system-brfss. Accessed 1 August 2024.
Henchoz Y, Dupuis M, Deline S, Studer J, Baggio S, N’Goran AA, Daeppen JB, Gmel G. Associations of physical activity and sport and exercise with at-risk substance use in young men: a longitudinal study. Prev Med. 2014;64:27–31. https://doi.org/10.1016/j.ypmed.2014.03.022.
Jarjou’i A, Izbicki G. Medical cannabis in asthmatic patients. Isr Med Assoc J. 2020;22(4):232–5.
Lima TM, Santiago NR, Alves ECR, Chaves DSA, Visacri MB. Use of cannabis in the treatment of animals: a systematic review of randomized clinical trials. Anim Health Res Rev. 2022;23(1):25–38. https://doi.org/10.1017/S1466252321000189
Lowin T, Tingting R, Zurmahr J, Classen T, Schneider M, Pongratz G. Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts. Cell Death Dis. 2020;11(8). https://doi.org/10.1038/s41419-020-02892-1.
Merrill RM. A national survey of marijuana use among U.S. adults according to obesity status, 2016–2022. Cannabis Cannabinoid Res. 2024. https://doi.org/10.1089/can.2024.0069.
National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. https://www.ncbi.nlm.nih.gov/books/NBK2003/. Accessed 17 Jun 2024.
National Institute on Aging. Exercising With Chronic Conditions. 2020. https://www.nia.nih.gov/health/exercise-and-physical-activity/exercising-chronic-conditions. Accessed 17 Jun 2024.
Ogle WL, Gold GJ, Coppen LE, Copriviza C. How and why adults use cannabis during physical activity. J Cannabis Res. 2022;4(1):24. https://doi.org/10.1186/s42238-022-00134-z.
Ong LQ, Bellettiere J, Alvarado C, Chavez P, Berardi V. Cannabis use, sedentary behavior, and physical activity in a nationally representative sample of US adults. Harm Reduct J. 2021;18(1):48. https://doi.org/10.1186/s12954-021-00496-2.
Pacheco-Colón I, Salamanca MJ, Coxe S, Hawes SW, Gonzalez R. Exercise, decision-making, and cannabis-related outcomes among adolescents. Subst Use Misuse. 2021;56(7):1035–44. https://doi.org/10.1080/10826084.2021.1906279.
Pierannunzi C, Hu SS, Balluz L. A systematic review of publications assessing reliability and validity of the Behavioral Risk Factor Surveillance System (BRFSS), 2004–2011. BMC Med Res Methodol. 2013;13:49 (2013). https://doi.org/10.1186/1471-2288-13-49
Rissetto V, What You Need to Know About Inflammation When You Have Diabetes. EatingWell Published July 6, 2021. https://www.eatingwell.com/article/7909041/what-you-need-to-know-about-inflammation-when-you-have-diabetes/#:~:text=Chronic%20inflammation%20is%20a%20risk. Accessed 1 August 2024.
Romero-Zerbo SY, García-Fernández M, Espinosa-Jiménez V, Pozo-Morales M, Escamilla-Sánchez A, Sánchez-Salido L, et al. The atypical cannabinoid Abn-CBD reduces inflammation and protects liver, pancreas, and adipose tissue in a mouse model of prediabetes and non-alcoholic fatty liver disease. Front Endocrinol (Lausanne). 2020;11:103. https://doi.org/10.3389/fendo.2020.00103.
Shannon S, Lewis N, Lee H, Hughes S. Cannabidiol in anxiety and sleep: a large case series. Perm J. 2019;23(1):18–41. https://doi.org/10.7812/tpp/18-041.
Skelley JW, Deas CM, Curren Z, Ennis J. Use of cannabidiol in anxiety and anxiety-related disorders. J Am Pharm Assoc (2003). 2020;60(1):253–61. https://doi.org/10.1016/j.japh.2019.11.008.
Sklenárová M, Šíma M, Slanař O. Effects of cannabidiol in inflammation: a review of pre-clinical and clinical findings. Prague Med Rep. 2023;124(3):216–29. https://doi.org/10.14712/23362936.2023.17.
Steinmetz K. Why are there so many different names for weed? http://time.com/4747501/420-day-weed-marijuana-pot-slang/. Accessed 1 August 2024.
Tan WC, Lo C, Jong A, Xing L, Fitzgerald MJ, Vollmer WM, Buist SA, Sin DD. Vancouver Burden of Obstructive Lung Disease (BOLD) research group. Marijuana and chronic obstructive lung disease: a population-based study. CMAJ. 2009;180(8):814–20. https://doi.org/10.1503/cmaj.081040.
Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis GA, Vogiatzi G, Papaioannou S, Deftereos S, Tousoulis D. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol. 2019;14(1):50–9. https://doi.org/10.15420/ecr.2018.33.1.
Vela J, Dreyer L, Petersen KK, Lars AN, Duch KS, Kristensen S. Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis. Pain. 2021;163(6). https://doi.org/10.1097/j.pain.0000000000002466.
Verrico CD, Wesson S, Konduri V, Hofferek CJ, Vazquez-Perez J, Blair E, Dunner K Jr, Salimpour P, Decker WK, Halpert MM. A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain. Pain. 2020;161(9):2191–202. https://doi.org/10.1097/j.pain.0000000000001896
Vidot DC, Bispo JB, Hlaing WM, Prado G, Messiah SE. Moderate and vigorous physical activity patterns among marijuana users: results from the 2007–2014 National Health and Nutrition examination surveys. Drug Alcohol Depend. 2017;178:43–8. https://doi.org/10.1016/j.drugalcdep.2017.05.004.
Weiss L, Zeira M, Reich S, Har-Noy M, Mechoulam R, Slavin S, Gallily R. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity. 2006;39(2):143–51. https://doi.org/10.1080/08916930500356674.
Wieckiewicz G, Stokłosa I, Stokłosa M, Gorczyca P, Pudlo R. Cannabidiol (CBD) in the self-treatment of depression-exploratory study and a new phenomenon of concern for psychiatrists. Front Psychiatry. 2022;13:837946. https://doi.org/10.3389/fpsyt.2022.837946.
Wilcox S, Der Ananian C, Abbott J, Vrazel J, Ramsey C, Sharpe PA, Brady T. Perceived exercise barriers, enablers, and benefits among exercising and nonexercising adults with arthritis: Results from a qualitative study. Arthritis Rheum. 2006;55(4):616 − 27. https://doi.org/10.1002/art.22098.
World Health Organization. Physical status: the use and interpretation of anthropometry. Report Of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1-452.
Wright M, Di Ciano P, Brands B. Use of cannabidiol for the treatment of anxiety: a short synthesis of pre-clinical and clinical evidence. Cannabis Cannabinoid Res. 2020;5(3):191–6. https://doi.org/10.1089/can.2019.0052.
Xue Y, Diep C, Zhao HJ, Wijeysundera DN, Clarke H, Ladha KS. Recent cannabis use and accelerometer-measured physical activity and sedentary behavior among young-to-midlife adults: an analysis of the National Health and Nutrition Examination Survey from 2011 to 2014. Cannabis Cannabinoid Res. 2024;13. https://doi.org/10.1089/can.2023.0244.
Yang KH, Tam RM, Satybaldiyeva N, Kepner W, Han BH, Moore AA, Palamar JJ. Trends in past-month cannabis use among US adults across a range of disabilities and health conditions, 2015–2019. Prev Med. 2023;177:107768. https://doi.org/10.1016/j.ypmed.2023.
YorkWilliams SL, Gust CJ, Mueller R, Bidwell LC, Hutchison KE, Gillman AS, Bryan AD. The new runner’s high? Examining relationships between cannabis use and exercise behavior in states with legalized cannabis. Front Public Health. 2019;7:99. https://doi.org/10.3389/fpubh.2019.00099.
